- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
Adamis Pharma is a drug manufacturers - specialty & generic business based in the US. Adamis Pharma shares (ADMP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.49 – the same closing value as a week prior. Adamis Pharma employs 11 staff and has a trailing 12-month revenue of around $5 million.
Our top picks for where to buy Adamis Pharma stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Adamis Pharma stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ADMP. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Adamis Pharma stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Adamis Pharma stock price (NASDAQ: ADMP)
Use our graph to track the performance of ADMP stocks over time.Adamis Pharma shares at a glance
Latest market close | $0.49 |
---|---|
52-week range | $0.47 - $0.67 |
50-day moving average | $0.90 |
200-day moving average | $6.11 |
Wall St. target price | $0.42 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-10.14 |
Is it a good time to buy Adamis Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Adamis Pharma price performance over time
Historical closes compared with the close of $0.4901 from 2023-11-09
1 week (2024-10-10) | N/A |
---|---|
1 month (2024-09-17) | N/A |
3 months (2024-07-17) | N/A |
6 months (2024-04-17) | N/A |
1 year (2023-10-20) | -15.60% |
---|---|
2 years (2022-10-21) | 226.73% |
3 years (2021-10-17) | N/A |
5 years (2019-10-21) | 0.5539 |
Adamis Pharma financials
Revenue TTM | $5 million |
---|---|
Gross profit TTM | $-1,431,408 |
Return on assets TTM | -104.5% |
Return on equity TTM | -784.96% |
Profit margin | 0% |
Book value | $-4.24 |
Market Capitalization | $7.3 million |
TTM: trailing 12 months
Adamis Pharma share dividends
We're not expecting Adamis Pharma to pay a dividend over the next 12 months.
Have Adamis Pharma's shares ever split?
Adamis Pharma's shares were split on a 1:70 basis on 21 May 2023 . So if you had owned 70 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Adamis Pharma shares – just the quantity. However, indirectly, the new 6900% higher share price could have impacted the market appetite for Adamis Pharma shares which in turn could have impacted Adamis Pharma's share price.
Adamis Pharma share price volatility
Over the last 12 months, Adamis Pharma's shares have ranged in value from as little as $0.47 up to $0.67. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adamis Pharma's is 1.2777. This would suggest that Adamis Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Adamis Pharma overview
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California. .
Frequently asked questions
nullWhat percentage of Adamis Pharma is owned by insiders or institutions?
Currently 7.811% of Adamis Pharma shares are held by insiders and 16.589% by institutions. How many people work for Adamis Pharma?
Latest data suggests 11 work at Adamis Pharma. When does the fiscal year end for Adamis Pharma?
Adamis Pharma's fiscal year ends in December. Where is Adamis Pharma based?
Adamis Pharma's address is: 11682 El Camino Real, San Diego, CA, United States, 92130 What is Adamis Pharma's ISIN number?
Adamis Pharma's international securities identification number is: US00547W2089 What is Adamis Pharma's CUSIP number?
Adamis Pharma's Committee on Uniform Securities Identification Procedures number is: 00547W109
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question